SUPRAFLEX-TALENT trial 3yr follow-up has been presented at EuroPCR 2021

At EuroPCR 2021  TALENT 3yrs follow up has been presented. Supraflex stent showed to be as safe and effective as Xience family stent in all-comers population.

Latest News:

EUKON at PADUA Course: HYDRA in complex anatomy

Shared experience at the heart of structural heart education. On…

Read More >

Supraflex Cruz evidence presented at TCT 2025

In November 2025, EUKON shared an update from Sahajanand Medical…

Read More >

LaaGuarder: first European clinical use announced by EUKON

In January 2026, EUKON announced the first clinical use in…

Read More >